January 24, 2025 press release from the U.S. Department of Justice.
Pfizer has agreed to pay nearly $60 million to settle allegations that its subsidiary, Biohaven, engaged in illegal kickback schemes before Pfizer acquired the company.
The DOJ alleged that Biohaven violated anti-kickback laws by providing financial incentives for prescribing the migraine drug Nurtec ODT.
“The department will use every tool at its disposal to prevent pharmaceutical manufacturers from undermining the objectivity of treatment decisions by health care providers.”
Let's start with the truth!
Support the Broken Science Initiative.
Subscribe today →
recent posts
Cancer as a metabolic disease—and the case against the somatic mutation theory
Metabolic health, medical education, and the case for bringing clinicians and coaches together
Metabolic therapies, mitochondrial dysfunction, and what’s holding back progress
